273 related articles for article (PubMed ID: 25889343)
1. Human neural stem cell transplantation in ALS: initial results from a phase I trial.
Mazzini L; Gelati M; Profico DC; Sgaravizzi G; Projetti Pensi M; Muzi G; Ricciolini C; Rota Nodari L; Carletti S; Giorgi C; Spera C; Domenico F; Bersano E; Petruzzelli F; Cisari C; Maglione A; Sarnelli MF; Stecco A; Querin G; Masiero S; Cantello R; Ferrari D; Zalfa C; Binda E; Visioli A; Trombetta D; Novelli A; Torres B; Bernardini L; Carriero A; Prandi P; Servo S; Cerino A; Cima V; Gaiani A; Nasuelli N; Massara M; Glass J; Sorarù G; Boulis NM; Vescovi AL
J Transl Med; 2015 Jan; 13():17. PubMed ID: 25889343
[TBL] [Abstract][Full Text] [Related]
2. Results from Phase I Clinical Trial with Intraspinal Injection of Neural Stem Cells in Amyotrophic Lateral Sclerosis: A Long-Term Outcome.
Mazzini L; Gelati M; Profico DC; Sorarù G; Ferrari D; Copetti M; Muzi G; Ricciolini C; Carletti S; Giorgi C; Spera C; Frondizi D; Masiero S; Stecco A; Cisari C; Bersano E; De Marchi F; Sarnelli MF; Querin G; Cantello R; Petruzzelli F; Maglione A; Zalfa C; Binda E; Visioli A; Trombetta D; Torres B; Bernardini L; Gaiani A; Massara M; Paolucci S; Boulis NM; Vescovi AL;
Stem Cells Transl Med; 2019 Sep; 8(9):887-897. PubMed ID: 31104357
[TBL] [Abstract][Full Text] [Related]
3. Transplantation of spinal cord-derived neural stem cells for ALS: Analysis of phase 1 and 2 trials.
Glass JD; Hertzberg VS; Boulis NM; Riley J; Federici T; Polak M; Bordeau J; Fournier C; Johe K; Hazel T; Cudkowicz M; Atassi N; Borges LF; Rutkove SB; Duell J; Patil PG; Goutman SA; Feldman EL
Neurology; 2016 Jul; 87(4):392-400. PubMed ID: 27358335
[TBL] [Abstract][Full Text] [Related]
4. Safety and Clinical Effects of Mesenchymal Stem Cells Secreting Neurotrophic Factor Transplantation in Patients With Amyotrophic Lateral Sclerosis: Results of Phase 1/2 and 2a Clinical Trials.
Petrou P; Gothelf Y; Argov Z; Gotkine M; Levy YS; Kassis I; Vaknin-Dembinsky A; Ben-Hur T; Offen D; Abramsky O; Melamed E; Karussis D
JAMA Neurol; 2016 Mar; 73(3):337-44. PubMed ID: 26751635
[TBL] [Abstract][Full Text] [Related]
5. Intraspinal neural stem cell transplantation in amyotrophic lateral sclerosis: phase 1 trial outcomes.
Feldman EL; Boulis NM; Hur J; Johe K; Rutkove SB; Federici T; Polak M; Bordeau J; Sakowski SA; Glass JD
Ann Neurol; 2014 Mar; 75(3):363-73. PubMed ID: 24510776
[TBL] [Abstract][Full Text] [Related]
6. Lumbar intraspinal injection of neural stem cells in patients with amyotrophic lateral sclerosis: results of a phase I trial in 12 patients.
Glass JD; Boulis NM; Johe K; Rutkove SB; Federici T; Polak M; Kelly C; Feldman EL
Stem Cells; 2012 Jun; 30(6):1144-51. PubMed ID: 22415942
[TBL] [Abstract][Full Text] [Related]
7. Phase I trial of repeated intrathecal autologous bone marrow-derived mesenchymal stromal cells in amyotrophic lateral sclerosis.
Oh KW; Moon C; Kim HY; Oh SI; Park J; Lee JH; Chang IY; Kim KS; Kim SH
Stem Cells Transl Med; 2015 Jun; 4(6):590-7. PubMed ID: 25934946
[TBL] [Abstract][Full Text] [Related]
8. Fetal olfactory ensheathing cells transplantation in amyotrophic lateral sclerosis patients: a controlled pilot study.
Huang H; Chen L; Xi H; Wang H; Zhang J; Zhang F; Liu Y
Clin Transplant; 2008; 22(6):710-8. PubMed ID: 18673377
[TBL] [Abstract][Full Text] [Related]
9. Intraspinal stem cell transplantation in amyotrophic lateral sclerosis: a phase I safety trial, technical note, and lumbar safety outcomes.
Riley J; Federici T; Polak M; Kelly C; Glass J; Raore B; Taub J; Kesner V; Feldman EL; Boulis NM
Neurosurgery; 2012 Aug; 71(2):405-16; discussion 416. PubMed ID: 22565043
[TBL] [Abstract][Full Text] [Related]
10. Transplantation of human adipose tissue-derived stem cells delays clinical onset and prolongs life span in ALS mouse model.
Kim KS; Lee HJ; An J; Kim YB; Ra JC; Lim I; Kim SU
Cell Transplant; 2014; 23(12):1585-97. PubMed ID: 24070071
[TBL] [Abstract][Full Text] [Related]
11. Distribution, differentiation, and survival of intravenously administered neural stem cells in a rat model of amyotrophic lateral sclerosis.
Mitrecić D; Nicaise C; Gajović S; Pochet R
Cell Transplant; 2010; 19(5):537-48. PubMed ID: 20350352
[TBL] [Abstract][Full Text] [Related]
12. Intraspinal stem cell transplantation in amyotrophic lateral sclerosis: a phase I trial, cervical microinjection, and final surgical safety outcomes.
Riley J; Glass J; Feldman EL; Polak M; Bordeau J; Federici T; Johe K; Boulis NM
Neurosurgery; 2014 Jan; 74(1):77-87. PubMed ID: 24018694
[TBL] [Abstract][Full Text] [Related]
13. Optimization of immunosuppressive therapy for spinal grafting of human spinal stem cells in a rat model of ALS.
Hefferan MP; Johe K; Hazel T; Feldman EL; Lunn JS; Marsala M
Cell Transplant; 2011; 20(8):1153-61. PubMed ID: 21669047
[TBL] [Abstract][Full Text] [Related]
14. Neural induction with neurogenin 1 enhances the therapeutic potential of mesenchymal stem cells in an amyotrophic lateral sclerosis mouse model.
Chan-Il C; Young-Don L; Heejaung K; Kim SH; Suh-Kim H; Kim SS
Cell Transplant; 2013; 22(5):855-70. PubMed ID: 22472631
[TBL] [Abstract][Full Text] [Related]
15. Stem cell therapy in amyotrophic lateral sclerosis: a methodological approach in humans.
Mazzini L; Fagioli F; Boccaletti R; Mareschi K; Oliveri G; Olivieri C; Pastore I; Marasso R; Madon E
Amyotroph Lateral Scler Other Motor Neuron Disord; 2003 Sep; 4(3):158-61. PubMed ID: 13129802
[TBL] [Abstract][Full Text] [Related]
16. Intrathecal transplantation of human neural stem cells overexpressing VEGF provide behavioral improvement, disease onset delay and survival extension in transgenic ALS mice.
Hwang DH; Lee HJ; Park IH; Seok JI; Kim BG; Joo IS; Kim SU
Gene Ther; 2009 Oct; 16(10):1234-44. PubMed ID: 19626053
[TBL] [Abstract][Full Text] [Related]
17. Stem cells for amyotrophic lateral sclerosis modeling and therapy: myth or fact?
Coatti GC; Beccari MS; Olávio TR; Mitne-Neto M; Okamoto OK; Zatz M
Cytometry A; 2015 Mar; 87(3):197-211. PubMed ID: 25645594
[TBL] [Abstract][Full Text] [Related]
18. Brain and spinal cord affected by amyotrophic lateral sclerosis induce differential growth factors expression in rat mesenchymal and neural stem cells.
Nicaise C; Mitrecic D; Pochet R
Neuropathol Appl Neurobiol; 2011 Feb; 37(2):179-88. PubMed ID: 20846186
[TBL] [Abstract][Full Text] [Related]
19. Olfactory ensheathing cell neurorestorotherapy for amyotrophic lateral sclerosis patients: benefits from multiple transplantations.
Chen L; Chen D; Xi H; Wang Q; Liu Y; Zhang F; Wang H; Ren Y; Xiao J; Wang Y; Huang H
Cell Transplant; 2012; 21 Suppl 1():S65-77. PubMed ID: 22507682
[TBL] [Abstract][Full Text] [Related]
20. Autologous bone marrow-derived stem cells in amyotrophic lateral sclerosis: a pilot study.
Prabhakar S; Marwaha N; Lal V; Sharma RR; Rajan R; Khandelwal N
Neurol India; 2012; 60(5):465-9. PubMed ID: 23135021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
